Watson Pharmaceuticals, Inc. announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey. The company has signed a lease for a 32,000-square-foot facility at the New Jersey Economic Development Authority's Technology Centre of New Jersey, a 50-acre complex consisting of lab, production and office space. Watson intends to initially invest approximately $4.5 million in outfitting the new facility. The company plans to immediately retrofit approximately 19,000 square feet of space for product development and analytical laboratories. The remaining 13,000 square feet will accommodate future expansion.